Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647930 · ClinicalTrials.gov registry record · NA
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
A NA study of Seroma, sponsored by Memorial Health University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03647930 is a NA study of Seroma that has completed, run by Memorial Health University Medical Center. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03647930, a NA study of Seroma, has completed, sponsored by Memorial Health University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
Conditions Studied
Interventions
- DEVICE Microporous Polysaccharide Hemospheres (MPH)
Study Locations (1)
Georgia
- Memorial Health University Medical Center - Savannah
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-05-15 |
| Est. Completion | 2015-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03647930
The ClinicalTrials.gov registry entry for NCT03647930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Health University Medical Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Seroma appearing as the primary indexed condition, and to 1 intervention - of which Microporous Polysaccharide Hemospheres (MPH) is the first listed.
NCT03647930 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03647930 about?
NCT03647930 is a clinical study titled "The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy". Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
What is the current status of trial NCT03647930?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-05-15. Estimated completion is 2015-03-06.
What conditions does trial NCT03647930 study?
This clinical trial studies the following conditions: Seroma.
What interventions are being tested in trial NCT03647930?
The interventions under investigation include: Microporous Polysaccharide Hemospheres (MPH) (DEVICE).
Who is sponsoring clinical trial NCT03647930?
This trial is sponsored by Memorial Health University Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03647930 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.